comparemela.com

Latest Breaking News On - Director yang qinping - Page 1 : comparemela.com

Kintor Pharma Receives IND Clearance by NMPA for KX-826 s Pivotal Study to Treat Male Alopecia Patients

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesKintor pharmaZhang jianzhongYang qinpingIr teamKintor pharmaceuticalUniversity people hospitalHuashan hospital of fudan universityPrnewswire kintor pharmaceutical limited pharmaPr teamNational medical products administrationDrug administration of the united statesPharmaceutical limitedProfessor zhang jianzhongPeking university peopleDirector yang qinping

Kintor Pharma Receives IND Clearance by NMPA for KX-826 s Pivotal Study to Treat Male Alopecia Patients

/PRNewswire/ Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and.

United statesKintor pharmaZhang jianzhongYang qinpingIr teamKintor pharmaceuticalUniversity people hospitalHuashan hospital of fudan universityPrnewswire kintor pharmaceutical limited pharmaPr teamNational medical products administrationDrug administration of the united statesPharmaceutical limitedProfessor zhang jianzhongPeking university peopleDirector yang qinping

Kintor Pharma Receives IND Clearance by NMPA for KX-826 s Pivotal Study to Treat Male Alopecia Patients

/PRNewswire/ Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and.

United statesKintor pharmaZhang jianzhongYang qinpingIr teamKintor pharmaceuticalUniversity people hospitalHuashan hospital of fudan universityPrnewswire kintor pharmaceutical limited pharmaPr teamNational medical products administrationDrug administration of the united statesPharmaceutical limitedProfessor zhang jianzhongPeking university peopleDirector yang qinping

vimarsana © 2020. All Rights Reserved.